Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital Palliative (DECAPAL)

February 5, 2013 updated by: Centre Francois Baclesse
The investigators propose a study that aims to develop a methodology for assessing this risk and the psychological consequences of the malignancy in the palliative phase.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

55

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
    • Calvados
      • Caen, Calvados, France, 14076
        • Centre Francois Baclesse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients with cancer in palliative cares

Description

Inclusion Criteria:

  • Patient (s) age (s) 18 or more
  • Patient (s) reach (s) of a cancer palliative stage
  • Patient (s) hospital (s) in the palliative care service
  • Patient (s) with cognitive function to an interrogation
  • Patient (s) having a physical condition for an interview lasting 45 minutes
  • Patient (s) that received clear information on the diagnosis and prognosis of their disease.
  • Free and informed consent signed

Exclusion Criteria:

  • Patient (s) age (s) under 18 years
  • Patient (s) under supervision or unable to give informed consent
  • Patient (s) whose cognitive functions do not allow an examination.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patients in palliative cares
patients with cancer in palliative cares An interview and will be offered to this patient during his hospitalization to be held (with the collection of personal and family psychiatric history of the patient, family and social context, the assessment of chronic pain and fatigue and quality of life,assessment of anxiety, Evaluation of symptoms of depression,asessment of suicide risk)
Behavioral: interview with a doctor for evaluating suicide risk

patients with cancer in palliative cares An interview and will be offered to this patient during his hospitalization to be held (with the collection of personal and family psychiatric history of the patient, family and social context, the assessment of chronic pain and fatigue and quality of life,assessment of anxiety, Evaluation of symptoms of depression,asessment of suicide risk)

--------------------------------------------------------------------------------

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
assessing the prevalence of suicide risk in patients with cancer admitted to a palliative care service.
Time Frame: at inclusion only, during hospitalization in palliative cares
assessing the prevalence of suicide risk in patients with cancer admitted to a palliative care service.
at inclusion only, during hospitalization in palliative cares

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate the feasibility of a methodology for estimating the risk of suicide in patients with cancer admitted to a palliative care service
Time Frame: at inclusion only, during hospitalization in palliative cares
Evaluate the feasibility of a methodology for estimating the risk of suicide in patients with cancer admitted to a palliative care service Questionnaires used are HADS Questionary, Scale HAMILTON, Scale BECK and Scale DUCHER
at inclusion only, during hospitalization in palliative cares
Assess the psychological impact of cancer pathology in patients in palliative
Time Frame: at inclusion only, during hospitalization in palliative cares
Assess the psychological impact of cancer pathology in patients in palliative by evaluating depression score (with HADS HAMILTON, BECK, DUCHER scales)
at inclusion only, during hospitalization in palliative cares
Identify risk factors for suicide in this patient population
Time Frame: at inclusion only, during hospitalization in palliative cares
Identify risk factors for suicide in this patient population with evaluation of type of cancer, psychiatric history, family and social context, quality of life
at inclusion only, during hospitalization in palliative cares

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Francois Baclesse

Investigators

  • Principal Investigator: Marie-Christine GRACH, MD, Centre Francois Baclesse

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (Actual)

February 1, 2013

Study Completion (Actual)

February 1, 2013

Study Registration Dates

First Submitted

April 30, 2012

First Submitted That Met QC Criteria

May 4, 2012

First Posted (Estimate)

May 7, 2012

Study Record Updates

Last Update Posted (Estimate)

February 6, 2013

Last Update Submitted That Met QC Criteria

February 5, 2013

Last Verified

April 1, 2012

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • DECAPAL

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on interview with a doctor for evaluating suicide risk

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe